RETRACTED: MiR-497-5p inhibits cell proliferation and metastasis in hepatocellular carcinoma by targeting insulin-like growth factor 1 (Retracted article. See vol. 11, 2023)

被引:31
|
作者
Xu, Guo-shu [1 ]
Li, Zi-wei [2 ]
Huang, Zhi-Ping [3 ]
Brunicard, F. Charles [2 ]
Jia, Fu [4 ]
Song, Chao [5 ]
Zou, Hai-jian [4 ]
Sun, Rui-fen [4 ]
机构
[1] Tongde Hosp Zhejiang Prov, Dept Oncol, Hangzhou, Zhejiang, Peoples R China
[2] Univ Toledo, Dept Surg, Coll Med & Life Sci, 2801 W Bancroft St, Toledo, OH 43606 USA
[3] Gen Hosp Guangzhou Mil Command PLA, Dept Hepatobiliary Surg, Guangzhou 510000, Guangdong, Peoples R China
[4] Yunnan Univ Chinese Tradit Med, Ctr Sci Res, Kunming, Yunnan, Peoples R China
[5] Kunming Med Univ, Natl Clin Key Specialty, Dept Orthoped, Yanan Hosp, Kunming, Yunnan, Peoples R China
来源
MOLECULAR GENETICS & GENOMIC MEDICINE | 2019年 / 7卷 / 10期
基金
美国国家卫生研究院;
关键词
biomarker; hepatocellular carcinoma; IGF1; miR-497-5p; proliferation; FACTOR-I; CANCER; MICRORNAS; MUSCLE; INVASION; IGF-1; AXIS;
D O I
10.1002/mgg3.860
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background MicroRNAs (miRNAs) play an important regulatory role in carcinogenesis and cancer progression. Aberrant expression of miR-497-5p has been reported in various human malignancies. However, the role of miR-497-5p in hepatocellular carcinoma (HCC) remains unclear. Results In this study, we found that miR-497-5p was downregulated in HCC tissues. The low level of miR-497-5p in HCC tumors was correlated with aggressive clinicopathological characteristics and predicted poor prognosis in HCC patients. The overexpression of miR-497-5p significantly inhibited HCC cell proliferation, colony formation, and metastasis in vitro and vivo. Bioinformatics analysis further identified insulin-like growth factor 1 (IGF1) as a novel target of miR-497-5p in HCC cells. Conclusion Our study suggested that miR-497-5p regulates HCC cell survival, partially through downregulation of IGF1. Therefore, the miR-497-5p/IGF1 axis might serve as a novel therapeutic target in patients with HCC.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] RETRACTION: MiR-497-5p inhibits cell proliferation and metastasis in hepatocellular carcinoma by targeting insulin-like growth factor 1 (Retraction of Vol 7, art no E00860, 2019)
    Xu, Guo-shu
    Li, Zi-wei
    Huang, Zhi-Ping
    Brunicardi, Charles F.
    Jia, Fu
    Song, Chao
    Zou, Hai-jian
    Sun, Rui-fen
    MOLECULAR GENETICS & GENOMIC MEDICINE, 2023, 11 (01):
  • [2] RETRACTED: Downregulation of miR-196-5p Induced by Hypoxia Drives Tumorigenesis and Metastasis in Hepatocellular Carcinoma (Retracted article. See vol. 14, 2023)
    Zheng, Hao
    Bi, Feng-rui
    Yang, Yuan
    Hong, Yong-gang
    Ni, Jun-sheng
    Ma, Long
    Liu, Ming-hua
    Hao, Li-qiang
    Zhou, Wei-ping
    Song, Li-hua
    Yan, Hong-Li
    HORMONES & CANCER, 2019, 10 (4-6): : 177 - 189
  • [3] RETRACTED: MicroRNA-495 suppresses cell proliferation and invasion of hepatocellular carcinoma by directly targeting insulin-like growth factor receptor-1 (Retracted article. See vol. 24, 2022)
    Ye, Ying
    Zhuang, Juhua
    Wang, Guangdong
    He, Saifei
    Zhang, Suiliang
    Wang, Guoyu
    Ni, Jing
    Wang, Jiening
    Xia, Wei
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2018, 15 (01) : 1150 - 1158
  • [4] RETRACTED: MicroRNA-503 suppresses cell proliferation and invasion in osteosarcoma via targeting insulin-like growth factor 1 receptor (Retracted article. See vol. 22, 2021)
    Wang, Zili
    Zheng, Chenhuang
    Jiang, Kunqi
    He, Jinshen
    Cao, Xu
    Wu, Song
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2017, 14 (02) : 1547 - 1553
  • [5] RETRACTED: Tripartite motif 16 inhibits hepatocellular carcinoma cell migration and invasion (Retracted article. See vol. 62, 2023)
    Li, Linlin
    Dong, Lei
    Qu, Xiaotong
    Jin, Shi
    Lv, Xiupeng
    Tan, Guang
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2016, 48 (04) : 1639 - 1649
  • [6] RETRACTED: MicroRNA-503 inhibits the proliferation and invasion of breast cancer cells via targeting insulin-like growth factor 1 receptor (Retracted article. See vol. 25, 2022)
    Yan, Jingwang
    Xu, Yonghuan
    Wang, Haipeng
    Du, Taiping
    Chen, Hao
    MOLECULAR MEDICINE REPORTS, 2017, 16 (02) : 1707 - 1714
  • [7] RETRACTED: MiR-490-5p Suppresses Cell Proliferation and Invasion by Targeting BUB1 in Hepatocellular Carcinoma Cells (Retracted article. See JUN, 2023)
    Xu, Bin
    Xu, Tangpeng
    Liu, Huali
    Min, Qian
    Wang, Shidong
    Song, Qibin
    PHARMACOLOGY, 2017, 100 (5-6) : 269 - 282
  • [8] RETRACTED: miR-361-5p inhibits hepatocellular carcinoma cell proliferation and invasion by targeting VEGFA (Retracted Article)
    Cui, Wenxian
    Li, Yuanguo
    Xu, Keqing
    Chen, Guijin
    Lu, Xiaoqun
    Duan, Qiuqin
    Kang, Zhirong
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2016, 479 (04) : 901 - 906
  • [9] RETRACTED: miR-365 targets ADAM10 and suppresses the cell growth and metastasis of hepatocellular carcinoma (Retracted article. See vol. 48, 2022)
    Liu, Yahui
    Zhang, Wei
    Liu, Songyang
    Liu, Kai
    Ji, Bai
    Wang, Yingchao
    ONCOLOGY REPORTS, 2017, 37 (03) : 1857 - 1864
  • [10] RETRACTED: MiR-154 inhibits the growth of laryngeal squamous cell carcinoma by targeting GALNT7 (Retracted article. See vol. 101, pg. 197, 2023)
    Niu, Jun-Tao
    Zhang, Li-Jun
    Huang, Yong-Wang
    Li, Chao
    Jiang, Ning
    Niu, Yuan-Jie
    BIOCHEMISTRY AND CELL BIOLOGY, 2018, 96 (06) : 752 - 760